{"id":35781,"date":"2020-06-30T14:05:24","date_gmt":"2020-06-30T18:05:24","guid":{"rendered":"http:\/\/reviewofmm.com\/?p=35781"},"modified":"2022-08-19T06:18:25","modified_gmt":"2022-08-19T10:18:25","slug":"santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia","status":"publish","type":"post","link":"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/","title":{"rendered":"Santen and Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia"},"content":{"rendered":"

June 30, 2020<\/strong><\/p>\n

\"\"Osaka, Japan and Singapore<\/strong> \u2014 Santen Pharmaceutical and Plano Pte today announced a strategic alliance to tackle the global burden of myopia. Under this strategic alliance, Plano has secured an investment from Santen. Santen, through Plano, will initiate to tackle the burden of myopia using both a holistic approach and innovative technological solutions.<\/p>\n

Santen, as a leading company in the field of ophthalmology, has cultivated expertise and capabilities specializing in ophthalmology based on a thorough customer orientation, including patients and health care professionals.<\/p>\n

Plano is an eye health tech company launched in 2017, founded by Mohamed Dirani. It is the first spin-off from the Singapore Eye Research Institute (SERI) \u2013 Singapore National Eye Centre (SNEC) Ophthalmic Technologies Incubator Programme, dedicated to accelerating highly promising ophthalmic R&D projects towards commercialization and medical deployment. The key products in the company\u2019s ecosystem include the plano application and the online optometry booking system, Plano Eyecheck.<\/p>\n

Myopia is one of the most common health problems in the world, affecting an estimated two billion people, or about 28% of the world\u2019s population. The number of people with myopia is expected to increase to 5 billion by the year 2050, which will be half of the world\u2019s population.1<\/sup> Developed countries in East and Southeast Asia have the highest rates of myopia in the world. As many as 80%-90% of teenagers and young adults in Singapore, Hong Kong and Taiwan, and 96.5% of 19-year-old men in South Korea have myopia.2<\/sup> Just 60 years ago, only 10%-20% of people in China had myopia.3<\/sup> Myopia has also become more common in Europe and the United States, where it now affects up to 40% of people.4<\/sup> Treating myopia costs Asian economies $328 billion every year5<\/sup>, with Singapore alone spending $755 million annually.6<\/sup><\/p>\n

Shigeo Taniuchi, President and CEO of Santen said, \u201cI am pleased to have a strategic alliance with Plano.\u00a0 Santen will, through Plano, by this strategic alliance, initiate in Singapore to raise awareness and support prevention and management of myopia in everyday life, as well as to expand the novel solutions to the region and beyond. With a recognition of rapid increase of myopia as a social issue, as a global leader in ophthalmology, Santen will work closely with Plano to resolve social issues related to myopia and to improve QOL of the patients around the world.\u201d<\/p>\n

\u201cThis funding and strategic alliance with Santen will play an instrumental role in growing Plano\u2019s user engagement, strengthen its big data analytics and artificial intelligence (AI) capabilities, and drive its international expansion plans. The strategic alliance with Santen, who recognize myopia as a material issue, is very important as we collectively embark on our future objectives to advance Plano\u2019s products and services, expand its myopia-centered ecosystem into the region and introduce new and people-centered products for the management of myopia. We are eager to get to work with the excellent team at Santen,\u201d said Plano\u2019s Managing Director Associate Professor Mohamed Dirani. \u201cTo align with Santen, who have shown leadership in ophthalmic care for over 130 years, is a humbling one. This alliance will provide the team at Plano with the added confidence, mentorship, and new opportunities to more effectively deliver its pioneering services in Singapore and the region. I am honored to be part of this journey and believe that this alliance will take Plano to even greater heights.\u201d<\/p>\n

Professor Wong Tien Yin, Medical Director of the Singapore National Eye Centre said, \u201cMyopia is a major public health problem in Asia and globally. We need to continue to raise awareness of the impact of the disease, its major risk factors and how we can slow its progression to prevent visual impairment. In children, a combination of increasing opportunities for outdoor activities and reducing excessive near-work activities are important strategies. We are very happy to see this strategic alliance being created between Plano, a startup company which was created within SERI\/SNEC\u2019s incubator framework, and Santen, a leading ophthalmic company with whom we have been working for several years on a broad strategic research and development collaboration. Plano\u2019s growth is a testament to the ability of Singapore\u2019s clinical centers to create internationally competitive and successful startups.\u201d<\/p>\n

Plano users can look forward to a series of exciting announcements that include a new app interface for both parents and children, improved product functionality, and for the first time in the world, an AI-driven calculator for the development, progression and stabilization of myopia in children and teenagers.<\/p>\n

1. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-42.<\/p>\n

2. Dolin E. The myopia boom. Nature. 2015;519(7543):276-8.<\/p>\n

3. Morgan IG, French AN, Ashby RS, Guo X, Ding X, He M, et al. The epidemics of myopia: Aetiology and prevention. Progress in Retinal & Eye Research. 2017.<\/p>\n

4. Vitale S, Sperduto RD, Ferris FL, 3rd. Increased prevalence of myopia in the United States between 1971- 1972 and 1999-2004. Arch Ophthalmol. 2009;127(12):1632-9.<\/p>\n

5. World Health Organization. The impact of myopia and high myopia: Report of the Joint World Health Organization \u2013 Brien Holden Vision Institute Global Scientific Meeting on Myopia. University of New South Wales, Sydney, Australia: 2015.<\/p>\n

6. Zheng YF, Pan CW, Chay J, Wong TY, Finkelstein E, Saw SM. The economic cost of myopia in adults aged over 40 years in Singapore. Investigative Ophthalmology & Visual Science. 2013;54(12):7532-7.<\/p>\n","protected":false},"excerpt":{"rendered":"

June 30, 2020 Osaka, Japan and Singapore \u2014 Santen Pharmaceutical and Plano Pte today announced a strategic alliance to tackle the global burden of myopia. Under this strategic alliance, Plano has secured an investment from Santen. Santen, through Plano, will initiate to tackle the burden of myopia using both a holistic approach and innovative technological solutions. Santen, as a leading company in the field of ophthalmology, has cultivated expertise and capabilities specializing in ophthalmology based on a thorough customer orientation, including patients and health care professionals. Plano is an eye health tech company launched in 2017, founded by Mohamed Dirani. It is the first spin-off from the Singapore Eye Research Institute (SERI) \u2013 Singapore National Eye Centre (SNEC) Ophthalmic Technologies Incubator Programme, dedicated to accelerating highly promising ophthalmic R&D projects towards commercialization and medical deployment. The key products in the company\u2019s ecosystem include the plano application and the online optometry booking system, Plano Eyecheck. Myopia is one of the most common health problems in the world, affecting an estimated two billion people, or about 28% of the world\u2019s population. The number of people with myopia is expected to increase to 5 billion by the year 2050, which will be half of the world\u2019s population.1 Developed countries in East and Southeast Asia have the highest rates of myopia in the world. As many as 80%-90% of teenagers and young adults in Singapore, Hong Kong and Taiwan, and 96.5% of 19-year-old men in South Korea have myopia.2 Just 60 years ago, only 10%-20% of people in China had myopia.3 Myopia has also become more common in Europe and the United States, where it now affects up to 40% of people.4 Treating myopia costs Asian economies $328 billion every year5, with Singapore alone spending $755 million annually.6 Shigeo Taniuchi, President and CEO of Santen said, \u201cI am pleased to have a strategic alliance with Plano.\u00a0 Santen will, through Plano, by this strategic alliance, initiate in Singapore to raise awareness and support prevention and management of myopia in everyday life, as well as to expand the novel solutions to the region and beyond. With a recognition of rapid increase of myopia as a social issue, as a global leader in ophthalmology, Santen will work closely with Plano to resolve social issues related to myopia and to improve QOL of the patients around the world.\u201d \u201cThis funding and strategic alliance with Santen will play an […]<\/p>\n","protected":false},"author":295,"featured_media":18426,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1733],"tags":[2021,2315,2082,2023,2154,2155,2157,2156],"yoast_head":"\nSanten and Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia - Review of Myopia Management<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Santen and Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia - Review of Myopia Management\" \/>\n<meta property=\"og:description\" content=\"June 30, 2020 Osaka, Japan and Singapore \u2014 Santen Pharmaceutical and Plano Pte today announced a strategic alliance to tackle the global burden of myopia. Under this strategic alliance, Plano has secured an investment from Santen. Santen, through Plano, will initiate to tackle the burden of myopia using both a holistic approach and innovative technological solutions. Santen, as a leading company in the field of ophthalmology, has cultivated expertise and capabilities specializing in ophthalmology based on a thorough customer orientation, including patients and health care professionals. Plano is an eye health tech company launched in 2017, founded by Mohamed Dirani. It is the first spin-off from the Singapore Eye Research Institute (SERI) \u2013 Singapore National Eye Centre (SNEC) Ophthalmic Technologies Incubator Programme, dedicated to accelerating highly promising ophthalmic R&D projects towards commercialization and medical deployment. The key products in the company\u2019s ecosystem include the plano application and the online optometry booking system, Plano Eyecheck. Myopia is one of the most common health problems in the world, affecting an estimated two billion people, or about 28% of the world\u2019s population. The number of people with myopia is expected to increase to 5 billion by the year 2050, which will be half of the world\u2019s population.1 Developed countries in East and Southeast Asia have the highest rates of myopia in the world. As many as 80%-90% of teenagers and young adults in Singapore, Hong Kong and Taiwan, and 96.5% of 19-year-old men in South Korea have myopia.2 Just 60 years ago, only 10%-20% of people in China had myopia.3 Myopia has also become more common in Europe and the United States, where it now affects up to 40% of people.4 Treating myopia costs Asian economies $328 billion every year5, with Singapore alone spending $755 million annually.6 Shigeo Taniuchi, President and CEO of Santen said, \u201cI am pleased to have a strategic alliance with Plano.\u00a0 Santen will, through Plano, by this strategic alliance, initiate in Singapore to raise awareness and support prevention and management of myopia in everyday life, as well as to expand the novel solutions to the region and beyond. With a recognition of rapid increase of myopia as a social issue, as a global leader in ophthalmology, Santen will work closely with Plano to resolve social issues related to myopia and to improve QOL of the patients around the world.\u201d \u201cThis funding and strategic alliance with Santen will play an […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/\" \/>\n<meta property=\"og:site_name\" content=\"Review of Myopia Management\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-30T18:05:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-19T10:18:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/reviewofmm.com\/wp-content\/uploads\/2018\/03\/3-28-18hand2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"724\" \/>\n\t<meta property=\"og:image:height\" content=\"406\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Robert Burke\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Robert Burke\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/\",\"url\":\"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/\",\"name\":\"Santen and Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia - Review of Myopia Management\",\"isPartOf\":{\"@id\":\"https:\/\/reviewofmm.com\/#website\"},\"datePublished\":\"2020-06-30T18:05:24+00:00\",\"dateModified\":\"2022-08-19T10:18:25+00:00\",\"author\":{\"@id\":\"https:\/\/reviewofmm.com\/#\/schema\/person\/cbe4923ca5bdcf416c076d835288cd7d\"},\"breadcrumb\":{\"@id\":\"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/reviewofmm.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Santen and Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/reviewofmm.com\/#website\",\"url\":\"https:\/\/reviewofmm.com\/\",\"name\":\"Review of Myopia Management\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/reviewofmm.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/reviewofmm.com\/#\/schema\/person\/cbe4923ca5bdcf416c076d835288cd7d\",\"name\":\"Robert Burke\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/reviewofmm.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/dc944161fbaa7ac90485faba73bfa04c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/dc944161fbaa7ac90485faba73bfa04c?s=96&d=mm&r=g\",\"caption\":\"Robert Burke\"},\"sameAs\":[\"http:\/\/rlburkejr@cox.net\"],\"url\":\"https:\/\/reviewofmm.com\/author\/bob-burke\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Santen and Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia - Review of Myopia Management","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/","og_locale":"en_US","og_type":"article","og_title":"Santen and Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia - Review of Myopia Management","og_description":"June 30, 2020 Osaka, Japan and Singapore \u2014 Santen Pharmaceutical and Plano Pte today announced a strategic alliance to tackle the global burden of myopia. Under this strategic alliance, Plano has secured an investment from Santen. Santen, through Plano, will initiate to tackle the burden of myopia using both a holistic approach and innovative technological solutions. Santen, as a leading company in the field of ophthalmology, has cultivated expertise and capabilities specializing in ophthalmology based on a thorough customer orientation, including patients and health care professionals. Plano is an eye health tech company launched in 2017, founded by Mohamed Dirani. It is the first spin-off from the Singapore Eye Research Institute (SERI) \u2013 Singapore National Eye Centre (SNEC) Ophthalmic Technologies Incubator Programme, dedicated to accelerating highly promising ophthalmic R&D projects towards commercialization and medical deployment. The key products in the company\u2019s ecosystem include the plano application and the online optometry booking system, Plano Eyecheck. Myopia is one of the most common health problems in the world, affecting an estimated two billion people, or about 28% of the world\u2019s population. The number of people with myopia is expected to increase to 5 billion by the year 2050, which will be half of the world\u2019s population.1 Developed countries in East and Southeast Asia have the highest rates of myopia in the world. As many as 80%-90% of teenagers and young adults in Singapore, Hong Kong and Taiwan, and 96.5% of 19-year-old men in South Korea have myopia.2 Just 60 years ago, only 10%-20% of people in China had myopia.3 Myopia has also become more common in Europe and the United States, where it now affects up to 40% of people.4 Treating myopia costs Asian economies $328 billion every year5, with Singapore alone spending $755 million annually.6 Shigeo Taniuchi, President and CEO of Santen said, \u201cI am pleased to have a strategic alliance with Plano.\u00a0 Santen will, through Plano, by this strategic alliance, initiate in Singapore to raise awareness and support prevention and management of myopia in everyday life, as well as to expand the novel solutions to the region and beyond. With a recognition of rapid increase of myopia as a social issue, as a global leader in ophthalmology, Santen will work closely with Plano to resolve social issues related to myopia and to improve QOL of the patients around the world.\u201d \u201cThis funding and strategic alliance with Santen will play an […]","og_url":"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/","og_site_name":"Review of Myopia Management","article_published_time":"2020-06-30T18:05:24+00:00","article_modified_time":"2022-08-19T10:18:25+00:00","og_image":[{"width":724,"height":406,"url":"https:\/\/reviewofmm.com\/wp-content\/uploads\/2018\/03\/3-28-18hand2.jpg","type":"image\/jpeg"}],"author":"Robert Burke","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Robert Burke","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/","url":"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/","name":"Santen and Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia - Review of Myopia Management","isPartOf":{"@id":"https:\/\/reviewofmm.com\/#website"},"datePublished":"2020-06-30T18:05:24+00:00","dateModified":"2022-08-19T10:18:25+00:00","author":{"@id":"https:\/\/reviewofmm.com\/#\/schema\/person\/cbe4923ca5bdcf416c076d835288cd7d"},"breadcrumb":{"@id":"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/reviewofmm.com\/"},{"@type":"ListItem","position":2,"name":"Santen and Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia"}]},{"@type":"WebSite","@id":"https:\/\/reviewofmm.com\/#website","url":"https:\/\/reviewofmm.com\/","name":"Review of Myopia Management","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/reviewofmm.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/reviewofmm.com\/#\/schema\/person\/cbe4923ca5bdcf416c076d835288cd7d","name":"Robert Burke","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/reviewofmm.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/dc944161fbaa7ac90485faba73bfa04c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dc944161fbaa7ac90485faba73bfa04c?s=96&d=mm&r=g","caption":"Robert Burke"},"sameAs":["http:\/\/rlburkejr@cox.net"],"url":"https:\/\/reviewofmm.com\/author\/bob-burke\/"}]}},"parsely":{"version":"1.1.0","meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"Santen and Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia","url":"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/reviewofmm.com\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\/"},"thumbnailUrl":"https:\/\/reviewofmm.com\/wp-content\/uploads\/2018\/03\/3-28-18hand2-150x150.jpg","image":{"@type":"ImageObject","url":"https:\/\/reviewofmm.com\/wp-content\/uploads\/2018\/03\/3-28-18hand2.jpg"},"articleSection":"Latest Myopia News","author":[{"@type":"Person","name":"Robert Burke"}],"creator":["Robert Burke"],"publisher":{"@type":"Organization","name":"Review of Myopia Management","logo":""},"keywords":["mohamed dirani","myopia news briefs\\","plano eyecheck","plano pte","santen pharmaceutical","shigeo taniuchi","singapore national eye centre","wong tien yin"],"dateCreated":"2020-06-30T18:05:24Z","datePublished":"2020-06-30T18:05:24Z","dateModified":"2022-08-19T10:18:25Z"},"rendered":"<script type=\"application\/ld+json\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Santen and Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia\",\"url\":\"https:\\\/\\\/reviewofmm.com\\\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\\\/\",\"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/reviewofmm.com\\\/santen-and-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia\\\/\"},\"thumbnailUrl\":\"https:\\\/\\\/reviewofmm.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/3-28-18hand2-150x150.jpg\",\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/reviewofmm.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/3-28-18hand2.jpg\"},\"articleSection\":\"Latest Myopia News\",\"author\":[{\"@type\":\"Person\",\"name\":\"Robert Burke\"}],\"creator\":[\"Robert Burke\"],\"publisher\":{\"@type\":\"Organization\",\"name\":\"Review of Myopia Management\",\"logo\":\"\"},\"keywords\":[\"mohamed dirani\",\"myopia news briefs\\\\\",\"plano eyecheck\",\"plano pte\",\"santen pharmaceutical\",\"shigeo taniuchi\",\"singapore national eye centre\",\"wong tien yin\"],\"dateCreated\":\"2020-06-30T18:05:24Z\",\"datePublished\":\"2020-06-30T18:05:24Z\",\"dateModified\":\"2022-08-19T10:18:25Z\"}<\/script>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/reviewofmm.com\/p.js"},"cc_featured_image_caption":{"caption_text":"","source_text":"","source_url":""},"_links":{"self":[{"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/posts\/35781"}],"collection":[{"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/users\/295"}],"replies":[{"embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/comments?post=35781"}],"version-history":[{"count":1,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/posts\/35781\/revisions"}],"predecessor-version":[{"id":44221,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/posts\/35781\/revisions\/44221"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/media\/18426"}],"wp:attachment":[{"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/media?parent=35781"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/categories?post=35781"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/tags?post=35781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}